Preferred Pharmaceuticals, Inc. has recalled approximately 260,882 units of Ranitidine Tablets (150 mg and 300 mg) because an impurity called N-nitrosodimethylamine (NDMA) was detected in the product. This medication is typically used to treat heartburn and stomach ulcers. Consumers should check their medicine cabinets for the affected bottles, which include 14, 30, 60, 90, and 100-count sizes sold across several states. Because this is a medication recall, you should consult with your healthcare provider or pharmacist regarding the safety of your current prescription and to discuss alternative treatments.
The product contains NDMA, a substance that is classified as a probable human carcinogen. Long-term exposure to levels above acceptable limits may increase the risk of developing cancer.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.